<DOC>
	<DOCNO>NCT01105546</DOCNO>
	<brief_summary>The study evaluate efficacy safety prophylactic treatment recombinant activate FVII reduce frequency joint bleeds development joint damage child hemophilia A develop high-titer inhibitor .</brief_summary>
	<brief_title>rFVIIa Prophylaxis Children With Hemophilia A Inhibitors</brief_title>
	<detailed_description>This multicentre , randomise , control study design gain evidence advantage prophylactic , daily treatment recombinant activate FVII compare conventional demand therapy reduce bleeding frequency preserve orthopaedic status hemophilic child inhibitor .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patients hemophilia A treated factor VIII demand prophylaxis develop inhibitor factor VIII ≤ 2 year time first inhibitor detection . Highresponding inhibitor ( historical peak &gt; 5 BU/mL ) know anamnestic response case negative inhibitor titre . Candidates start daily ITI FVIII dose range 50 IU/Kg/day 200 IU/Kg/day Maximal two bleeding joint within last 6 month enter study maximal six joint bleeds joint within 2 year Adequate venous access daily infusion capable ( caregiver ) reconstitute inject study drug Informed consent parent legal guardian . ITI already start Known suspect hypersensitivity active substance excipients study drug Administration investigational product within 30 day prior randomisation Other coagulation disorder congenital hemophilia A . Family history thrombosis early age ( &lt; 40 year ) , know thrombophilia , previous thrombosis include catheterrelated deep vein thrombosis , previous neonatal thrombosis . Known pseudo tumour Known severe liver disease Platelet count &lt; 50,000 platelets/µL screening Surgery within one month plan major and/or orthopaedic surgery .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>hemophilia A</keyword>
	<keyword>inhibitor</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>immune tolerance induction</keyword>
</DOC>